Leading experts across oncology specialties preview the key studies and data they are most anticipating ahead of the 2025 ESMO Congress.
Sagus Sampath, MD
Advertisement
Sagus Sampath, MD, is an associate clinical professor and medical director of the Department of Radiation Oncology at City of Hope in Duarte, California
Articles by Sagus Sampath, MD
Sagus Sampath, MD, discusses the safety profile of consolidative radiotherapy administered in conjunction with osimertinib in advanced EGFR-mutant NSCLC
Sagus Sampath, MD, assistant professor, Department of Radiation Oncology, City of Hope, discusses the safety profile of immunotherapy in combination with radiation in the treatment of patients with lung cancer.
Sagus Sampath, MD, assistant professor, Department of Radiation Oncology, City of Hope, discusses combinations of immunotherapy and radiation for the treatment of patients with non-small cell lung cancer (NSCLC).
Advertisement
Latest Updated Articles
Dr. Sampath on Immunotherapy and Radiation Combinations in NSCLCPublished: December 21st 2017 | Updated:
Dr. Sampath on Safety of Immunotherapy Plus Radiation in Lung CancerPublished: February 15th 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
4
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma
5